Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
A 66.66 1.58% 1.04
ANIP closed up 0.21 percent on Monday, April 22, 2024, on 60 percent of normal volume.
Earnings due: May 6
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 1.58%
Spinning Top Other 1.58%
Lower Bollinger Band Walk Weakness 1.58%
Gapped Up Strength 1.58%
Oversold Stochastic Weakness 1.58%
50 DMA Support Bullish 1.80%
Bullish Engulfing Bullish 1.80%
Stochastic Buy Signal Bullish 1.80%
Pocket Pivot Bullish Swing Setup 1.80%
Lower Bollinger Band Walk Weakness 1.80%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 4 hours ago
Up 1% about 4 hours ago
60 Minute Opening Range Breakout about 4 hours ago
Rose Above 10 DMA about 4 hours ago
10 DMA Resistance about 24 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ANI Pharmaceuticals, Inc. Description

ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Suspension Manufacturing Facilities Contract Manufacturing Chloroarenes Contract Manufacturing Services Cough Estrogen Antiemetics Testosterone Antacid Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers

Is ANIP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 70.81
52 Week Low 36.99
Average Volume 159,680
200-Day Moving Average 58.47
50-Day Moving Average 64.81
20-Day Moving Average 67.25
10-Day Moving Average 66.20
Average True Range 1.48
RSI (14) 46.52
ADX 22.87
+DI 18.27
-DI 21.28
Chandelier Exit (Long, 3 ATRs) 66.36
Chandelier Exit (Short, 3 ATRs) 68.65
Upper Bollinger Bands 70.17
Lower Bollinger Band 64.33
Percent B (%b) 0.22
BandWidth 8.67
MACD Line -0.04
MACD Signal Line 0.47
MACD Histogram -0.5031
Fundamentals Value
Market Cap 1.34 Billion
Num Shares 20.4 Million
EPS 0.54
Price-to-Earnings (P/E) Ratio 121.52
Price-to-Sales 2.57
Price-to-Book 2.68
PEG Ratio 1.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 67.41
Resistance 3 (R3) 67.46 66.91 67.11
Resistance 2 (R2) 66.91 66.46 66.89 67.01
Resistance 1 (R1) 66.27 66.18 66.00 66.22 66.91
Pivot Point 65.72 65.72 65.59 65.70 65.72
Support 1 (S1) 65.08 65.27 64.81 65.03 64.33
Support 2 (S2) 64.53 64.99 64.51 64.23
Support 3 (S3) 63.89 64.53 64.13
Support 4 (S4) 63.84